Securities and Exchange Commission v. Markman Biologics Corp.

Opinion

2 UNITED STATES DISTRICT COURT 3 DISTRICT OF NEVADA 4 * * * 5 Securities and Exchange Commission, Case No. 2:23-cv-00288-APG-DJA 6 Plaintiff, 7 Order v. 8 Markman Biologics Corp. and Alan 9 Shinderman,

10 Defendants,

11 and

12 Aspen Asset Management Services, LLC

13 Relief Defendant.

14 15 The law firms of Lucosky Brookman LLP and Marquis Aurbach move to withdraw as 16 counsel of record for Defendant Markman Biologics Corp. but will remain as counsel for 17 Defendant Alan Shinderman and Aspen Management Services, LLC. (ECF No. 26). The Court 18 finds that counsel has met the requirements of Local Rule IA 11-6(b). Additionally, no party has 19 opposed the motion, constituting their consent to the Court granting it under Local Rule 7-2(d). 20 Because it is a corporation, Markman Biologics Corp. must retain counsel to proceed in this 21 action. See Reading Intern., Inc. v. Malulani Group, Ltd., 814 F.3d 1046, 1053 (9th Cir. 2016) 22 (explaining that corporations must be represented by counsel). 23 24 IT IS THEREFORE ORDERED that the motion to withdraw (ECF No. 26) is granted. 25 IT IS FURTHER ORDERED that Markman Biologics Corp. must file a status report 26 regarding its retention of counsel on or before October 30, 2023. 27 1 IT IS FURTHER ORDERED that the Clerk of Court is kindly directed to place 2 Markman Biologics Corp.’s last known addresses on the docket:

4 Markman Biologics Corp. Attn: Spencer Flores 5 13155 Noel Road Suite 900 6 Dallas, TX 75240 Email: spencerflor21@gmail.com 7 8 9 IT IS FURTHER ORDERED that the Clerk of Court is kindly directed to mail this order 10 to Markman Biologics Corp. at the address listed above. 11 12 DATED: September 29, 2023 13 DANIEL J. ALBREGTS 14 UNITED STATES MAGISTRATE JUDGE 15 16 17 18 19 20 21 22 23 24 25 26 27